Nisoldipine how supplied storage and handling

Revision as of 04:20, 20 February 2014 by Abdurahman Khalil (talk | contribs) (Created page with "__NOTOC__ {{Nisoldipine}} {{CMG}}; {{AE}}:{{AK}} '''''For patient information about Nisoldipine, click here.''''' ==HOW SUPPLIED== SUL...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Nisoldipine
SULAR® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Nisoldipine
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: :Abdurahman Khalil, M.D. [2]

For patient information about Nisoldipine, click here.

HOW SUPPLIED

SULAR extended release tablets are supplied as 8.5 mg and 17 mg round film coated tablets and 25.5 mg and 34 mg elliptic film coated tablets. The different strengths can be identified as follows:

SULAR Tablets are supplied in bottles of 100:

Protect from light and moisture. Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature]. Dispense in tight, light-resistant containers.